Bret Haymore is a Rheumatology/Immunology physician. OpenAlex indexes 20 publications with 491 citations (h-index 8).
Overview
Scholarship
indexed output and impact (OpenAlex)Distinct works indexed by OpenAlex.
Total citations across indexed works.
Hirsch index, productivity × impact (OpenAlex).
Clinical & industry
trials, payments and federal fundingContact
The practice address and phone this provider lists in the federal NPPES (CMS) registry.
Practice address
4716 W Urbana St
Suite 211
Broken Arrow, OK 740125997
Telephone
918-994-5200Registry record last updated 22 Sept 2016.
Industry payments
28 companies reported payments to CMS in program years 2021 onward. These are public disclosures, not judgments. The latest:
- ARS Pharmaceuticals Operations, Inc.Program year20259 payments
- Regeneron Healthcare Solutions, Inc.Program year202511 payments
- GENZYME CORPORATIONProgram year202510 payments
Payment records matched to this physician's NPI in CMS Open Payments, program years 2021 onward.
Medicare prescribing footprint (2024)
The drugs this prescriber writes for Medicare patients, grouped by drug class and therapeutic area. Every percentage is a share of their total prescribing, so you can see what they prescribe most. These are proportions, not patient counts or dollar amounts. No condition is inferred: the claims record what was prescribed, never why.
Respiratory
81.8%Corticosteroid29.5%Fluticasone Propionate43%Trelegy Ellipta22%Breo Ellipta19%Symbicort16%Part D<11 patientsLeukotriene Receptor Antagonist22.1%Montelukast Sodium100%Part D≥66 patients+ 4 more classes in this area
Metabolism & gastrointestinal
15%Proton pump inhibitor6.9%Omeprazole100%Part D≥29 patientsH2 blocker4.6%Famotidine100%Part D≥17 patients+ 2 more classes in this area
Blood & clotting
1.7%Salt solutions1.7%Sodium Chloride100%Part D<11 patients
Drug classes come from the WHO ATC and U.S. National Library of Medicine (RxClass) classifications; prescribing counts come from the CMS Medicare Part D Prescribers file. Each drug is counted once, under its primary class. Medicare fee-for-service only, so no Medicare Advantage, commercial, or pediatric prescribing is included. CMS publishes this data about 17 months after the fact.
Publications
Matched to this physician's OpenAlex author record; most-cited works shown first.
- Frequency of mold and pollen mixing in allergen immunotherapy prescriptions within a large health care system, 1990-2010
Journal of Allergy and Clinical Immunology
2011 - Effect of allergen immunotherapy practice parameters on cat extract prescribing patterns, 1993–2009
Annals of Allergy Asthma & Immunology
2011 - Correlation between eosinophilic oesophagitis and aeroallergens
Alimentary Pharmacology & Therapeutics
2009 - USE OF ANGIOTENSIN RECEPTOR BLOCKERS AFTER ANGIOEDEMA WITH AN ANGIOTENSIN-CONVERTING ENZYME INHIBITOR
Annals of Allergy Asthma & Immunology
2009 - Imported fire ant immunotherapy prescribing patterns in a large health care system during a 17-year period
Annals of Allergy Asthma & Immunology
2009
Similar KOLs
Other experts from the same institution or the same specialty.
David J. Hunter
The University of Sydney
Aziz Sheikh
Universiti Malaysia Terengganu
Nima Hafezi‐Nejad
The University of Sydney
Gelin Xu
Second Affiliated Hospital of Nanjing Medical University
A basic profile from our physician directory: identity and practice contact from the federal NPPES registry, research from OpenAlex, trials from ClinicalTrials.gov, payments from CMS Open Payments — shown itemized where we have matched records, as a count where we only have a total. This person hasn't been through our full identity-adjudication pipeline yet, so funding, congress activity and public presence aren't shown. Absence of a section means “not yet looked,” never “none found.”